XECS – ADMIRED

Introduction to bipolar disorder and its impact

Bipolar disorder (BD) presents a significant challenge to individuals affected by it, manifesting in extreme mood swings ranging from mania to depression. This condition affects approximately 1.9% of the population in the Netherlands, translating to a considerable disease burden estimated at €400 million annually. The chronic nature of BD, coupled with the delayed treatment typically initiated post-severe episodes, underscores the necessity for improved diagnostic and management strategies.

Challenges in current healthcare approaches

By virtue of its chronic nature the disease burden for a single patient is significantly higher compared to more prevalent disorders such as depression or anxiety. Furthermore most individuals with BD only receive treatment after a severe episode. This delay not only jeopardises the health of the affected individuals but also has direct and indirect consequences for their support network. The current healthcare system lacks proactive and anticipated diagnosis and treatment approaches, leading to suboptimal patient outcomes and increased healthcare costs.

Project goals and innovations

A Dutch consortium aims to revolutionize BD management through the development of a clinically-validated platform. This initiative focuses on utilizing an array of data sources and self-reported metrics, alongside advanced machine learning tools, to offer predictive insights into potential mood episodes. The core innovations include:

  • Mobile Apps and Wearables: These tools will provide users with the ability to monitor mood fluctuations, identify triggers, and recognize early warning signs of BD episodes.
  • Integration with Healthcare Platforms: Seamless communication with healthcare providers will be facilitated, ensuring timely interventions.
  • Machine Learning and Predictive Analytics: Algorithms will analyze mood data to offer personalized insights and relapse prevention strategies.
  • Data-Driven Psychological Interventions: Development of interventions that leverage collected data for optimal clinical outcomes and self-management support.

Expected outcomes and impact

The envisioned modular, personalized solution aims to empower BD patients, their support networks, and healthcare providers with advanced monitoring and management capabilities. By enabling early detection and intervention, the project seeks to minimize the risk of relapse and hospitalization, thereby improving quality of life for those affected by BD and reducing the overall healthcare burden.

This ambitious project represents a significant step forward in the management of bipolar disorder, promising to enhance patient outcomes through the innovative use of technology and data analytics.

Research duration

Start date: 1-Jan-2024
End date: 1-Jan-2027

Voeg je header hier toe

In dit whitepaper vind je meer informatie over de NiceDay formule en onze unieke manier van werken. Lees snel wat NiceDay voor jou kan betekenen.

Share this

Partners

 

Project funded by

© 2024 - NiceDay Nederland